IRCT20120415009472N22尚未招募3 期
Effect of Ellagic acid supplementation on disease severity, expression of involved genes in pathogenesis, and levels of immunity and inflammatory biomarkers in patients with Multiple Sclerosis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Patient informed consent
- •Disease diagnosis based on McDonald's criteria and MRI by a neurologist
- •EDSS score less than 5.5
- •Relapsing-remitting status of the disease
- •age between 18 and 55 years
排除标准
- •Reluctance to participate in the study
- •Take nutritional supplements, antioxidants, and ellagic acid during a month before the start of the study and during the study (except for routine supplements that are part of the treatment plan for all patients, including vitamin D)
- •Taking nonsteroidal anti-inflammatory drugs, estrogen, progesterone, immunosuppressives, diuretics, and corticosteroids during a month before the study
- •Patients with inflammatory bowel disease (IBD), rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes, and other autoimmune diseases are excluded from the study.
- •Pregnancy and lactation
研究者
相似试验
招募中
3 期
Ellagic acid supplementation effect in patients with type 2 diabetesIRCT20141025019669N13Qazvin University of Medical Sciences44
已完成
3 期
Ellagic acid supplementation in patient with irritabe bowel syndromeIrritable bowel syndrome.K58.0Irritable bowel syndrome with diarrheaIRCT20141025019669N11Qazvin University of Medical Sciences44
招募中
3 期
Ellagic acid supplementation effect in patients with Major DepressiveMajor depressive episode.Major depressive disorder, single episodeIRCT20141025019669N15Mazandaran University of Medical Sciences60
招募中
3 期
Ellagic acid supplementation in patients with non-alcoholic fatty liver diseaseon alcoholic fatty liver disease.Other specified inflammatory liver diseasesK75.8IRCT20141025019669N21Qazvin University of Medical Sciences44
已完成
3 期
Ellagic acid supplementation in women with the poly cystic ovarian syndromePolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20141025019669N12Qazvin University of Medical Sciences60